Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Immunovant Inc (NASDAQ: IMVT) was $15.22 for the day, down -3.67% from the previous closing price of $15.80. In other words, the price has decreased by -$3.67 from its previous closing price. On the day, 1.02 million shares were traded.
Ratios:
Our analysis of IMVT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 23 ’25 when Stout Jay S sold 1,925 shares for $14.79 per share. The transaction valued at 28,471 led to the insider holds 209,243 shares of the business.
Geffner Michael sold 2,349 shares of IMVT for $34,742 on Apr 23 ’25. The Chief Medical Officer now owns 225,370 shares after completing the transaction at $14.79 per share. On Apr 16 ’25, another insider, Barnett Eva Renee, who serves as the Chief Financial Officer of the company, sold 2,993 shares for $14.89 each. As a result, the insider received 44,566 and left with 396,774 shares of the company.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -11.79%, while the 200-Day Moving Average is calculated to be -38.78%.
Shares Statistics:
A total of 147.20M shares are outstanding, with a floating share count of 68.32M. Insiders hold about 59.78% of the company’s shares, while institutions hold 49.28% stake in the company.
